• Subject: Re: Release of License
  • From: "Simon Coulter" <shc@xxxxxxxxxxxxxxxxx>
  • Date: Mon, 25 Oct 99 09:29:29 +1000
  • Importance: Normal

M
Hello Bob,

The QAZARLS (Release License) API will do what you want.  It and sundry others 
are documented in 
the OS/400 Software Product APIs manual.

Regards,
Simon Coulter.


 FlyByNight Software         AS/400 Technical Specialists       
 Eclipse the competition - run your business on an IBM AS/400.  
                                                                
 Phone: +61 3 9419 0175      Mobile: +61 0411 091 400           
 Fax:   +61 3 9419 0175      mailto: shc@flybynight.com.au      
                                                                
 Windoze should not be open at Warp speed.                      

//--- forwarded letter -------------------------------------------------------
> X-Mailer: Microsoft Outlook IMO, Build 9.0.2416 (9.0.2910.0)
> Date: Wed, 20 Oct 1999 11:45:19 -0500
> From: "Bob Randall" <BLR@airxcel.com>
> To: MIDRANGE-L@midrange.com
> Reply-To: MIDRANGE-L@midrange.com
> Subject: Release of License
> Importance: Normal

> 
> Is there a way through a CL command or something to release a licensed user?
> 
> The way I do it now is by doing a WRKLICINF, select the license key, and
> work with users. Then simply select release license for the user. I would
> like to program this function.
> 
> TIA,
> Bob Randall

+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---

This thread ...


Follow On AppleNews
Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2019 by midrange.com and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available on our policy page. If you have questions about this, please contact [javascript protected email address].